E-LIB Suche - Ergebnisse für: Baldacci, Simon

1

Activating point mutations in the MET kinase domain represe..:

Pecci, Federica ; Nakazawa, Seshiru ; Ricciuti, Biagio...
Cancer Discovery. , 2024

Link: https://doi.org/10.1158/..

2

Characterization of 164 patients with NRAS mutated non-smal..:

Dehem, Agathe ; Mazieres, Julien ; Chour, Ali...
Lung Cancer. 186 (2023) - p. 107393 , 2023

Link: https://doi.org/10.1016/..

3

Lorlatinib for advanced anaplastic lymphoma kinase–positive..:

Baldacci, Simon ; Besse, Benjamin ; Avrillon, Virginie...
European Journal of Cancer. 166 (2022) - p. 51-59 , 2022

Link: https://doi.org/10.1016/..

4

Does bevacizumab increase joint pain in patients with cance..:

Vauléon, Enora ; Behal, Hélène ; Lebellec, Loïc...
Cancer Chemotherapy and Pharmacology. 87 (2021) 4 - p. 533-541 , 2021

Link: https://doi.org/10.1007/..

5

Complete and prolonged response to anti-PD1 therapy in an A..:

Baldacci, Simon ; Grégoire, Valérie ; Patrucco, Enrico...
Lung Cancer. 146 (2020) - p. 366-369 , 2020

Link: https://doi.org/10.1016/..

6

Relevance of Detection of Mechanisms of Resistance to ALK I..:

Jamme, Philippe ; Descarpentries, Clotilde ; Gervais, Radj...
Clinical Lung Cancer. 20 (2019) 4 - p. 297-304.e1 , 2019

Link: https://doi.org/10.1016/..

7

MET amplification increases the metastatic spread of EGFR-m..:

Baldacci, Simon ; Kherrouche, Zoulika ; Cockenpot, Vincent...
Lung Cancer. 125 (2018) - p. 57-67 , 2018

Link: https://doi.org/10.1016/..

8

The multiple paths towards MET receptor addiction in cancer:

Duplaquet, Leslie ; Kherrouche, Zoulika ; Baldacci, Simon...
Oncogene. 37 (2018) 24 - p. 3200-3215 , 2018

Link: https://doi.org/10.1038/..

9

Outcome of EGFR-mutated NSCLC patients with MET-driven resi..:

Baldacci, Simon ; Mazieres, Julien ; Tomasini, Pascale...
Oncotarget. 8 (2017) 62 - p. 105103-105114 , 2017

Link: https://doi.org/10.18632..

10

MA10.10 [18F]-FDG-PET/CT Early Response to Nivolumab in NSC..:

Bellevre, Dimitri ; Petyt, Gegory ; Collet, Guillaume...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S402 , 2017

Link: https://doi.org/10.1016/..

11

P1.03-018 FDG-PET/CT in Patients with EGFR-Mutated NSCLC Tr..:

Petyt, Gegory ; Bellevre, Dimitri ; Adens, Amaury...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S553 , 2017

Link: https://doi.org/10.1016/..

12

Exon 14 Deleted MET Receptor as a New Biomarker and Target ..:

Cortot, Alexis B. ; Kherrouche, Zoulika ; Descarpentries, Clotilde...
JNCI: Journal of the National Cancer Institute. 109 (2017) 5 - p. , 2017

Link: https://doi.org/10.1093/..

13

P3.02b-051 Outcome of Advanced EGFR-Mutated NSCLC Patients ..:

Baldacci, Simon ; Mazieres, Julien ; Tomasini, Pascale...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1219-S1220 , 2017

Link: https://doi.org/10.1016/..

14

BMET-31. DETECTION OF EGFR MUTATIONS IN THE CEREBRO-SPINAL ..:

Le Rhun, Emilie ; Grégoire, Valérie ; Girard, Edwina...
Neuro-Oncology. 18 (2016) suppl_6 - p. vi33-vi33 , 2016

Link: https://doi.org/10.1093/..

15

Defect in recruiting effector memory CD8+T-cells in maligna..:

Scherpereel, Arnaud ; Grigoriu, Bogdan Dragos ; Noppen, Marc...
BMC Cancer. 13 (2013) 1 - p. , 2013

Link: https://doi.org/10.1186/..